Intech Investment Management »

Allogene Therapeutics shares owned by Intech Investment Management

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Intech Investment Management from 13F filings

Historical chart of Intech Investment Management investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Intech Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Intech Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $116k 41k 2.80

More positions owned by Intech Investment Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
UnitedHealth (UNH)
Progressive Corporation (PGR)
Chipotle Mexican Grill (CMG)
Wal-Mart Stores (WMT)
Constellation Energy (CEG)
Netflix (NFLX)
Hca Holdings (HCA)

View all positions for Intech Investment Management

Top funds holding Allogene Therapeutics

Tpg Gp A
BlackRock
BlackRock
Vanguard Group
State Street Corporation
Capital World Investors
Lynx1 Capital Management
PRIMECAP Management Company
Citadel Advisors
T. Rowe Price Associates
Woodline Partners
Jpmorgan Chase & Co
Geode Capital Management
Two Sigma Investments
Wildcat Capital Management

View all funds holding Allogene Therapeutics